An Open-Label Study to Assess Safety (NCT03645499) | Clinical Trial Compass
CompletedPhase 1
An Open-Label Study to Assess Safety
United States88 participantsStarted 2018-04-04
Plain-language summary
An Open-Label study to assess safety
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Healthy male or non-pregnant female aged ≥ 18 years with a clinical diagnosis of plaque psoriasis.
✓. Definite clinical diagnosis of stable plaque psoriasis for at least 6 months.
✓. Subjects must be in good health and free from any clinically significant disease, including but not limited to, conditions that may interfere with the evaluation of plaque psoriasis.
Exclusion criteria
✕. Female Subjects who are pregnant, nursing or planning to become pregnant during study participation.
✕. History of allergy or sensitivity to retinoid, corticosteroids and/or history of any drug hypersensitivity or intolerance which, in the opinion of the Investigator, would compromise the safety of the Subject or the results of the study.